Growth Metrics

U S Physical Therapy (USPH) Cash & Equivalents (2016 - 2025)

U S Physical Therapy (USPH) has disclosed Cash & Equivalents for 16 consecutive years, with $35.6 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 14.0% to $35.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $35.6 million through Dec 2025, down 14.0% year-over-year, with the annual reading at $35.6 million for FY2025, 14.0% down from the prior year.
  • Cash & Equivalents hit $35.6 million in Q4 2025 for U S Physical Therapy, up from $31.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $160.7 million in Q2 2023 to a low of $17.9 million in Q1 2021.
  • Historically, Cash & Equivalents has averaged $63.3 million across 5 years, with a median of $36.7 million in 2022.
  • Biggest five-year swings in Cash & Equivalents: crashed 79.97% in 2021 and later skyrocketed 383.72% in 2023.
  • Year by year, Cash & Equivalents stood at $28.6 million in 2021, then grew by 10.6% to $31.6 million in 2022, then surged by 383.72% to $152.8 million in 2023, then crashed by 72.94% to $41.4 million in 2024, then dropped by 14.0% to $35.6 million in 2025.
  • Business Quant data shows Cash & Equivalents for USPH at $35.6 million in Q4 2025, $31.1 million in Q3 2025, and $34.1 million in Q2 2025.